This book examines genotoxic impurities and their impact on the pharmaceutical industry. Specific sections examine this from both a toxicological and analytical perspective. Within these sections, the book defines appropriate strategies to both assess and ultimately control genotoxic impurities, thus aiding the reader to develop effective control measures. An opening section covers the development of guidelines and the threshold of toxicological concern (TTC) and is followed by a section on safety aspects, including safety tests in vivo and vitro, and data interpretation. The second section addresses the risk posed by genotoxic impurities from outside sources and from mutagens within DNA. In the final section, the book deals with the quality perspective of genotoxic impurities focused on two critical aspects, the first being the analysis and the second how to practically evaluate the impurities.
"synopsis" may belong to another edition of this title.
ANDREW TEASDALE, PhD, is a senior QA executive with AstraZeneca and chairs the company's internal genotoxic impurities advisory group. With over fifteen years of experience in analytical chemistry and quality assurance, Dr. Teasdale has published a number of papers relating to GIs and has been a speaker on genotoxic impurities at a number of conferences. Dr. Teasdale has also led two expert groups working in the field of genotoxic impurities, including an analytical group in the UK and a Project Quality Research Institute (PQRI) working group, which focused on the critical area of sulfonate ester formation and control.
A one-stop reference to genotoxic impurities in pharmaceuticals
This volume examines the full range of issues the pharmaceutical industry faces when seeking to ensure control over the levels of genotoxic impurities in pharmaceuticals. It offers comprehensive practical guidance on how to both assess and control genotoxic impurities (GIs) through all phases of drug development.
Featuring contributed chapters by experts from both the quality assurance and toxicology fields, Genotoxic Impurities covers all topics from the ground up, using real-world examples and case studies to help readers meet the challenges of regulatory compliance. Other important features include:
A detailed review of current regulatory guidelines relating to GIs, including discussion of their implications and the thinking behind their development
A thorough evaluation of the threshold of toxicological concern (TTC) concept, along with an examination of the emerging evidence supporting the existence of thresholds even for DNA-reactive mutagens.
Step-by-step instructions , including both analytical and safety strategies, on how to evaluate risks posed by GIs
Discussion of the risks posed by GIs from other sources, i.e., dietary exposure and the endogenous production of genotoxins.
Specific advice on chromatographic strategy and other key analyticaltechniques, including the innovative use of NMR
The first comprehensive resource of its kind, Genotoxic Impurities is an indispensable reference for researchers and professionals in the pharmaceutical industry. It is also useful for regulatory professionals who need to interpret the regulatory guidelines covering GIs.
A one-stop reference to genotoxic impurities in pharmaceuticals
This volume examines the full range of issues the pharmaceutical industry faces when seeking to ensure control over the levels of genotoxic impurities in pharmaceuticals. It offers comprehensive practical guidance on how to both assess and control genotoxic impurities (GIs) through all phases of drug development.
Featuring contributed chapters by experts from both the quality assurance and toxicology fields, Genotoxic Impurities covers all topics from the ground up, using real-world examples and case studies to help readers meet the challenges of regulatory compliance. Other important features include:
A detailed review of current regulatory guidelines relating to GIs, including discussion of their implications and the thinking behind their development
A thorough evaluation of the threshold of toxicological concern (TTC) concept, along with an examination of the emerging evidence supporting the existence of thresholds even for DNA-reactive mutagens.
Step-by-step instructions , including both analytical and safety strategies, on how to evaluate risks posed by GIs
Discussion of the risks posed by GIs from other sources, i.e., dietary exposure and the endogenous production of genotoxins.
Specific advice on chromatographic strategy and other key analyticaltechniques, including the innovative use of NMR
The first comprehensive resource of its kind, Genotoxic Impurities is an indispensable reference for researchers and professionals in the pharmaceutical industry. It is also useful for regulatory professionals who need to interpret the regulatory guidelines covering GIs.
"About this title" may belong to another edition of this title.
Seller: Goodmediandmore, Asheville, NC, U.S.A.
hardcover. Condition: Very Good. Clean text, crisp pages. Very good overall condition. Ships next business day from NC. Seller Inventory # S115-HR3-99.95-063026-VG-0-021
Seller: HPB-Red, Dallas, TX, U.S.A.
hardcover. Condition: Good. Connecting readers with great books since 1972! Used textbooks may not include companion materials such as access codes, etc. May have some wear or writing/highlighting. We ship orders daily and Customer Service is our top priority! Seller Inventory # S_381160463
Seller: Goodwill of Silicon Valley, SAN JOSE, CA, U.S.A.
Condition: good. Supports Goodwill of Silicon Valley job training programs. The cover and pages are in Good condition! Any other included accessories are also in Good condition showing use. Use can include some highlighting and writing, page and cover creases as well as other types visible wear. Seller Inventory # GWSVV.0470499192.G
Seller: Studibuch, Stuttgart, Germany
hardcover. Condition: Sehr gut. 448 Seiten; 9780470499191.2 Gewicht in Gramm: 1. Seller Inventory # 1377389
Seller: BUCHSERVICE / ANTIQUARIAT Lars Lutzer, Wahlstedt, Germany
Condition: gut. 2011. Genotoxic Impurities: Strategies for Identification and Control In englischer Sprache. pages. Seller Inventory # BN573990